'Bloodbath': Shock as Trump fires thousands at HHS amid outbreaks

01 April

Donald Trump at the Kennedy Center

The United States is reportedly on pace for its worst year of measles infections this century, with 483 confirmed measles cases across 20 states. At the same time, 70 human cases of bird flu have been identified in 13 states. As these outbreaks of potentially deadly diseases escalate, with no clear resolution in sight, the Trump administration has begun the process of firing an estimated 10,000 to 20,000 employees at the U.S. Department of Health and Human Services.

Amid the ongoing bird flu outbreak, the "top FDA veterinarian working to help the Trump administration fight bird flu has been let go," according to Wall Street Journal health reporter Liz Essley Whyte.

Medical and public health experts are in shock and sounding the alarm.

"The FDA as we've known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed," remarked Dr. Robert Califf, who served twice as Commissioner of the Food and Drug Administration, under presidents Obama and Biden. He calls this "a dark day for public health" that history will see as "a huge mistake."

Dr. Califf says he is now hearing that firms are preparing to move research and development to Europe and China. He added, "maybe there's a plan to nurture the profound advances in medicine & tech on the horizon rather than promote unproven remedies like cod liver oil and supplements for serious diseases."

The Washington Post points to the "purge of leadership" at the U.S. health agencies that make up HHS. They include the Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), Food and Drug Administration (FDA), Health Resources and Services Administration (HRSA), National Institutes of Health (NIH), among others.

"At the National Institutes of Health, a nearly $48 billion biomedical research agency, at least five top leaders were put on leave," according to the Post. "Among those offered reassignment were the infectious-disease institute director Jeanne Marrazzo," who "had succeeded Anthony S. Fauci as director of the National Institute of Allergy and Infectious Diseases, an institute that helped lead the nation’s response to the coronavirus pandemic and that later became a target of Republicans."

Sam Stein at The Bulwark calls Tuesday's firings a "bloodbath," and a "mass culling."

"Multiple officials who work in the department told The Bulwark that entire offices were being eliminated, the conservative media outlet reported. "To get a fuller sense of the despair, head over to the NIH’s Reddit forum; or the HHS forum. It’s bleak. That’s what happens, we suppose, when a weeks-old administration decides that it will eliminate 10,000 full-time employees from one of its most critical departments."

"Generation of scientists, health care officials being wiped out," Stein wrote on social media.

Dr. Rob Davidson, executive director of the nonprofit Committee to Protect Health Care wrote: "Slashing 20,000 HHS jobs is reckless. Pairing that with Medicaid cuts? That’s not reform—it’s sabotage. You don’t 'fix' healthcare by gutting its core. People will suffer."

Claiming "streamlining," and "efficiency," HHS Secretary Robert F. Kennedy Jr. announced the layoffs late last week, declaring he "will eliminate an entire alphabet soup of departments, while preserving their core functions by merging them into a new organization called the Administration for a Healthy America or AHA. This overhaul will improve the health of the entire nation — to Make America Healthy Again."

Dr. Craig Spencer, an emergency room physician who treated Ebola patients and subsequently contracted the often deadly disease but survived, blasted the firings.

"Thousands of the best experts at FDA, NIH, and all across HHS are being terminated right now," Dr. Spencer wrote. "These are the people who make sure the medications you and your children take are safe. These are the people who perform and oversee research on cancer, infant health, and so so so much more. These are the people who make sure new devices that physicians and patients use are effective. These are the people who keep workers safe on the job and help prevent devastating injuries for workers all around the country. These are the people who track what drugs and medications are experiencing shortages so we can adapt. These are the people who help tackle HIV and other infectious diseases, asthma, lead poisoning, and everything else that makes many Americans sick. And now, thousands of them are gone. There is no way this makes Americans healthier. We will regret this."

STAT News reports that about twenty-five percent of the entire HHS workforce is expected to be eliminated:

"As of last week, it was estimated that the FDA would take the biggest cut, losing roughly 3,500 employees, or about 19% its workforce, followed by the Centers for Disease Control and Prevention, which was expected to lose ... about 18% of its staff. The National Institutes of Health was projected to lose about 1,200 employees, or about 6% of its workers."

Dr. Scott Gottlieb, who served as FDA Commissioner during President Donald Trump's first administration, did not appear to directly address the firings, but chose the day they are happening to warn about the destruction of the ecosystem that works to create new drugs, which includes HHS agencies like the FDA and the NIH.

"Twenty-five years ago, it was common to hear complaints about a 'drug lag'—the perception that Europeans routinely enjoyed medical advances years before their American counterparts. Through a generation of congressional actions, investments in expertise and hiring, and careful policymaking, we built the FDA into the most efficient, forward-leaning drug regulatory agency in the world—and established the U.S. as the global center of biopharmaceutical innovation. Today, the cumulative barrage on that drug-discovery enterprise, threatens to swiftly bring back those frustrating delays for American consumers, particularly affecting rare diseases and areas of significant unmet medical need."